Thoratec Announces First HeartMate III™ Human Implant And Start Of CE Mark Trial
June 27, 2014 at 08:31 AM EDT
Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and ...
